<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(2)</volume><submitter>Ohnishi M</submitter><pubmed_abstract>In the chronic phase after intracerebral hemorrhage (ICH), the aftereffect-associated lowering of motivation burdens many patients; however, the pathogenic mechanism is unclear. Here, we revealed for the first time that indoleamine 2, 3-dioxygenase (IDO) expression and enzyme activity are increased in the collagenase-induced murine ICH model. IDO is a rate-limiting enzyme situated at the beginning of the kynurenine pathway and converts tryptophan, a source of serotonin (5-hydroxytryptamine; 5-HT), to kynurenine. In this study, we showed that IDO is localized in 5-HTergic neurons. After ICH, the synaptosomal 5-HT level decreased, but this effect was neutralized by subcutaneous injections of 1-methyl tryptophan (MT), a specific IDO inhibitor. These results suggest that ICH-induced IDO weaken</pubmed_abstract><journal>PloS one</journal><pagination>e0273037</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9907831</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Indoleamine 2, 3-dioxygenase is responsible for low stress tolerance after intracerebral hemorrhage.</pubmed_title><pmcid>PMC9907831</pmcid><pubmed_authors>Aokawa H</pubmed_authors><pubmed_authors>Hata T</pubmed_authors><pubmed_authors>Akagi M</pubmed_authors><pubmed_authors>Ohnishi M</pubmed_authors><pubmed_authors>Inoue A</pubmed_authors><pubmed_authors>Yonemura S</pubmed_authors><pubmed_authors>Yamashita-Ibara M</pubmed_authors><pubmed_authors>Maehara S</pubmed_authors><pubmed_authors>Yokofujita O</pubmed_authors><pubmed_authors>Kotsuki M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Indoleamine 2, 3-dioxygenase is responsible for low stress tolerance after intracerebral hemorrhage.</name><description>In the chronic phase after intracerebral hemorrhage (ICH), the aftereffect-associated lowering of motivation burdens many patients; however, the pathogenic mechanism is unclear. Here, we revealed for the first time that indoleamine 2, 3-dioxygenase (IDO) expression and enzyme activity are increased in the collagenase-induced murine ICH model. IDO is a rate-limiting enzyme situated at the beginning of the kynurenine pathway and converts tryptophan, a source of serotonin (5-hydroxytryptamine; 5-HT), to kynurenine. In this study, we showed that IDO is localized in 5-HTergic neurons. After ICH, the synaptosomal 5-HT level decreased, but this effect was neutralized by subcutaneous injections of 1-methyl tryptophan (MT), a specific IDO inhibitor. These results suggest that ICH-induced IDO weaken</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-04T23:52:44.308Z</modification><creation>2025-04-04T23:52:44.308Z</creation></dates><accession>S-EPMC9907831</accession><cross_references><pubmed>36753496</pubmed><doi>10.1371/journal.pone.0273037</doi></cross_references></HashMap>